Market Research Logo

Novogen Limited (NRT) - Financial and Strategic SWOT Analysis Review

Novogen Limited (NRT) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Novogen Limited (Novogen) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on two main drug technology platforms, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM drugs that target the cancer cell cytoskeleton are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. SBP drugs that target cancer stem cells are being developed for the treatment of ovarian cancer and glioblastoma. The company’s major drug candidates include is Cantrixil (TRX-E-002-1); Trilexium (TRXE-009-1)and Anisina (ATM-3507). Novogen is headquartered in North Ryde, Australia.

Novogen Limited Key Recent Developments

Sep 05, 2016: Novogen Appoints Scientific Advisory Board To Guide Development Of Oncology Pipeline
Aug 29, 2016: Novogen Appoints Key Management Personnel To Drive Transition To A Development - Focused Organisation
Feb 05, 2016: Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
Dec 10, 2015: Novogen Appoints Dr James Garner as Chief Executive Officer
Aug 31, 2015: Novogen Announces The Outcome Of A Comprehensive Science Review

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Novogen Limited - Key Facts
Novogen Limited - Key Employees
Novogen Limited - Key Employee Biographies
Novogen Limited - Major Products and Services
Novogen Limited - Pharmaceutical Pipeline Products Data
Novogen Limited, Pipeline Products by Therapy Area
Novogen Limited, Pipeline Products by Development Phase
Novogen Limited - History
Novogen Limited - Company Statement
Novogen Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Novogen Limited - Business Description
Novogen Limited - Corporate Strategy
Novogen Limited - SWOT Analysis
SWOT Analysis - Overview
Novogen Limited - Strengths
Novogen Limited - Weaknesses
Novogen Limited - Opportunities
Novogen Limited - Threats
Novogen Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Novogen Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Novogen Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Novogen Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 05, 2016: Novogen Appoints Scientific Advisory Board To Guide Development Of Oncology Pipeline
Aug 29, 2016: Novogen Appoints Key Management Personnel To Drive Transition To A Development - Focused Organisation
Feb 05, 2016: Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
Dec 10, 2015: Novogen Appoints Dr James Garner as Chief Executive Officer
Aug 31, 2015: Novogen Announces The Outcome Of A Comprehensive Science Review
Aug 05, 2015: Novogen Strengthens Position In ATM Platform By Lodging New Patents
Jul 29, 2015: Newly Appointed Acting CEO Outlines Immediate Plans for Novogen
Jul 22, 2015: Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board
Jun 12, 2015: Novogen to Present at Bio International Convention Philadelphia 2015
Jun 03, 2015: Novogen Expands Board with Two New Appointments
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Novogen Limited, Key Facts
Novogen Limited, Key Employees
Novogen Limited, Key Employee Biographies
Novogen Limited, Major Products and Services
Novogen Limited, Number of Pipeline Products by Therapy Area
Novogen Limited, Number of Pipeline Products by Development Stage
Novogen Limited, Pipeline Products By Therapy Area and Development Phase
Novogen Limited, History
Novogen Limited, Subsidiaries
Novogen Limited, Joint Venture
Novogen Limited, Key Competitors
Novogen Limited, Ratios based on current share price
Novogen Limited, Annual Ratios
Novogen Limited, Interim Ratios
Novogen Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Novogen Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Novogen Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Novogen Limited, Pipeline Products by Therapy Area
Novogen Limited, Pipeline Products by Development Phase
Novogen Limited, Performance Chart (2012 - 2016)
Novogen Limited, Ratio Charts
Novogen Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Novogen Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report